Ken Griffin Boston Scientific Corp Put Options Transaction History

Citadel Advisors LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	SELL	$57.6 - $68.62 $27.4 Million - $32.6 Million	-475,800 Reduced 70.86%	195,700 $13.4 Million
Q4 2023 Feb 14, 2024	SELL	$48.64 - $57.81 $13.6 Million - $16.2 Million	-280,200 Reduced 29.44%	671,500 $38.8 Million
Q3 2023 Nov 14, 2023	BUY	$50.19 - $54.68 $29.1 Million - $31.7 Million	579,700 Added 155.83%	951,700 $50.2 Million
Q2 2023 Aug 14, 2023	SELL	$49.72 - $54.64 $8.95 Million - $9.84 Million	-180,000 Reduced 32.61%	372,000 $20.1 Million
Q1 2023 May 15, 2023	BUY	$45.09 - $50.03 $17.6 Million - $19.5 Million	390,000 Added 240.74%	552,000 $27.6 Million

Q4 2022 Feb 14, 2023	SELL	$39.56 - $47.22 $11.5 Million - $13.7 Million	-290,200 Reduced 64.18%	162,000 $7.5 Million
Q3 2022 Nov 14, 2022	SELL	$36.71 - $109.66 $21.6 Million - $64.6 Million	-588,800 Reduced 56.56%	452,200 $17.5 Million

1,320

1.17B

5.92M

5.75M

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $111B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.